Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 48 261.9 |
96 | EP file number | EAKZ | 10 17 6627.7 |
97 | EP publication number | EPN | 2270048 |
54 | Designation/title | TI | Anti-NGF Antikörper und Verfahren zu ihrer Verwendung |
51 | IPC main class | ICM (ICMV) | C07K 16/22 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/395 (2006.01), A61P 25/04 (2006.01), C07K 14/48 (2006.01) |
22 | DE application date | DAT | Dec 24, 2003 |
96 | EP application date | EAT | Dec 24, 2003 |
43 | Date of first publication | OT | Jan 5, 2011 |
| Date of publication of grant | PET | Nov 11, 2015 |
71/73 | Applicant/owner | INH | Rinat Neuroscience Corp., South San Francisco, Calif., US |
72 | Inventor | IN | Shelton, David L., Oakland, CA 94618, US; Pons, Jaume, East Palo Alto, CA 94303, US; Rosenthal, Arnon, Woodside, CA 94062, US |
74 | Representative | VTR | Kraus & Lederer PartGmbB, 80539 München, DE |
| Address for service | | Kraus & Lederer PartGmbB, 80539 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 436905 P Dec 24, 2002
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 443522 P Jan 28, 2003
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 510006 P Oct 8, 2003
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002270048 Searchable text:
EP000002270048 Original document:
EP000002270048B1 Searchable text:
EP000002270048B1 |
43 | Date of first publication | EVT | Jan 5, 2011 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 28, 2024 (Show all update days)(Hide all update days)- Nov 28, 2024
- Procedures: Opposition procedure, Decision on revocation by EPO has become final, 29.07.2024: changed
- Nov 14, 2024
- Procedures: Opposition procedure, Decision on revocation by EPO has become final, 29.07.2024: new
- Procedures: Opposition procedure, Revocation by EPO, 29.07.2024: new
- May 23, 2024; May 2, 2024; Feb 22, 2024; Jan 4, 2024; Dec 26, 2023; Dec 22, 2023; Jun 28, 2022; Nov 16, 2021; Nov 17, 2020; Nov 21, 2019; Nov 22, 2018; Jan 17, 2018; Aug 10, 2017; Mar 16, 2017; Jan 11, 2017; Oct 20, 2016; Sep 15, 2016; Feb 11, 2016; Feb 6, 2016; Dec 23, 2015; Nov 18, 2015; Nov 12, 2015; Feb 15, 2013; Oct 13, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|